Company intelligence / Profile preview
Qualthera
Salt Lake City, Utah, United Statesqualthera.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Qualthera is a Salt Lake City-based biotechnology company dedicated to advancing precision oncology through its proprietary functional screening platform, Qual-Screen. The company's technology enables the rapid identification of optimal therapeutic combinations and the discovery of novel small molecule inhibitors for challenging targets like KRAS. By leveraging patient-derived models and high-throughput analysis, Qualthera aims to deliver personalized treatment strategies for patients with refractory solid tumors. Their lead programs focus on next-generation KRAS inhibitors designed to overcome resistance mechanisms seen with first-generation therapies.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Huntsman Cancer Institute
Beyond the preview
Go deeper on Qualthera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qualthera.